Suggested screening guidelines
| Cervical cancer screening for women with other HPV-related cancer |
| Cotesting HPV and cervical cytology every 3 years; |
| preferred for women age 30 and older |
| Annual cervical cytology for 3 years, then every 3 years if negative; preferred for women under age 30, or if HPV testing is unavailable |
| Anal cancer screening for women with other HPV-related high-grade anogenital dysplasia or cancer |
| Annual symptom query, visual inspection, and digital anorectal examination |
| Anal cytology can be considered, depending on the availability of high-resolution anoscopy (high-grade vulvar dysplasia and cancer are associated with higher risk than at other sites) |